HomePage >> Journals >> Economic Management Journal

Economic Management Journal

ISSN Print:2169-6020

ISSN Online:2169-6039

Email:emj@ivypub.org

Website: http://www.ivypub.org/emj

  0
  0

Paper Infomation

The Relationship between the Performance of Listed Companies in Pharmaceutical Manufacturing and Inventory Turnover, Operating Rate

Full Text(PDF, 236KB)

Author: Yutong Hai

Abstract: As an important part of the pharmaceutical industry, the pharmaceutical manufacturing industry is always at the battlefield of the international public health and health industry. At the same time, as a basic and strategic sub-industry in China's manufacturing industry, the medical manufacturing industry closely related to people’s livelihood which is not only related to social Responsibility but also plays a key role in China's economy today. For the Chinese people, the new medical reforms and the irreversible aging of the population have increased the nation’s total expenditure on health care. From January to October 2017, the pharmaceutical industry’s main business income was RMB 2,410.29 billion, a year-on-year increase of 13.10%. This is a 4.50 percentage point higher than the 10.30% growth rate in 2016. However, even if the circumstance of this industry is getting better,high growth also has a drag on the national health insurance system and the standard of living of the people. This article chooses to analyze the financial and operating-level factors of China's pharmaceutical manufacturing listed companies such as Inventory turnover rate and operating rate. Study the impact on the performance of China's pharmaceutical manufacturing listed companies. The results of the study will fill gaps in the research of this industry and help pharmaceutical manufacturing listed companies choose the right capital size, liabilities, and expansion strategies, and more effectively absorb the current development dividends of China’s “four new economy”, and use them rationally and effectively. Markets and complex and limited capital and resources of enterprises, as China's industry benchmarks continue to guide the rapid growth of the market. on the other hand, to help investor the empirical point of view better choice of investment targets. This paper uses data from 2007-2016 for randomly selecting 19 companies from 118 medical manufacturing listed companies classified by China Securities Regulatory Commission. After dealing with panel data, multiple inspections are performed on panel data. To avoid the deviation from the actual level of the regression results, the panel-corrected standard deviation model was used to derive the relationship between the operating-level factors of pharmaceutical manufacturing listed companies and their performance. The results of the study indicate that there is a positive correlation between Inventory turnover rate, operating rate and performance, which fills the domestic empirical research on this issue. This area of industry company performance is blank.

Keywords: Pharmaceutical Manufacturing Listed Companies, Corporation Performance, Panel Data, Inventory Turnover, Operating Rate of Return

References:

[1] Zhang Renfang. Analysis of the Factors Affecting the Performance of Private Listed Companies[J]. Qilu Zhutan, 2004, (06): 49-51. (in Chinese)

[2] Liu Na. Research and Enlightenment of Factors Affecting the Performance of Small and Medium-sized Listed Companies in China——Based on the Analysis of the GEM Listing[J]. Green Finance, 2010, (07): 42-43. (in Chinese)

[3] Fu Youhong. Financial Performance Evaluation of China's Manufacturing Listed Companies [D]. Wuhan University of Technology 2012. (in Chinese)

[4] Zhang Yong, Guo Haitao. Research on the Factors Affecting the Performance of Private Listed Companies[J]. Finance and Accounting Monthly, 2012, (12): 87-89. (in Chinese)

[5] Bao Xinzhong, Sun Wei, Tao Qiuyan, Sheng Xiaojuan. Research on the relationship between competition strategy, innovation research and development and corporate performance [J]. School of Management, Beijing Union University. Dongling School of Economics and Management, Beijing University of Science and Technology. 2014. (in Chinese)

[6] Chen Xiaoling. Research on the Influence Mechanism of Strategic Orientation and Innovation Model on Enterprise Performance[J]. School of Management, Zhejiang University. 2015. (in Chinese)

[7] Tong Meifang. Research on performance evaluation of automobile listed companies based on DEA model [D]. China University of Geosciences (Beijing).2011. (in Chinese)

[8] Li Xuezhen, Zhang Xue. Empirical Research on Human Capital and Enterprise Performance of Listed Companies[D]. Shandong Institute of Economics. 2010. (in Chinese)

[9] Liu Xiaoqing. The application of the revised Wall score method in the performance evaluation of biopharmaceutical listed companies [D]. Anhui University of Finance and Economics, 2017. (in Chinese)

[10] Gao Chunyan. Research on financial performance evaluation of listed companies in the pharmaceutical industry [D]. Yunnan University, 2015. (in Chinese)

[11] Xia Lizheng. Research on financial performance evaluation of pharmaceutical manufacturing listed companies [D]. University of Electronic Science and Technology of China, 2009. (in Chinese)

[12] Liu Qian. Construction of Enterprise Financial Performance Evaluation Model——Based on Principal Component Analysis[J]. Productivity Research, 2010(06): 249-250+254. (in Chinese)

[13] Yang Lei. Research on financial performance evaluation system of Daqing Huake Co., Ltd. based on DEA [D]. Harbin Institute of Technology, 2015. (in Chinese)

[14] Li Du. An empirical study on the correlation between corporate social responsibility and corporate financial performance [D]. Shijiazhuang Railway University, 2015. (in Chinese)

[15] Ding Zhen. Research on Financial Performance Evaluation of WH Pharmaceutical Company [D]. Tianjin University of Commerce, 2015. (in Chinese)

[16] Xiang Wei. Research on financing structure and performance of listed companies in pharmaceutical manufacturing [D]. Tianjin University of Finance and Economics, 2014. (in Chinese)

[17] Chi Guohua, Chi Xusheng. Research on the Evaluation System of Business Performance of China's Listed Companies[J]. Accounting Research, 2003(08): 45-47. (in Chinese)

[18] Bao Sihan. Research on the performance evaluation of Shanghai Pharmaceuticals' overall listing [D]. Shenzhen University, 2017. (in Chinese)

[19] Gu Xiuli. Research on Financial Performance Evaluation of Listed Companies in China's Pharmaceutical Manufacturing Industry [D]. East China Jiaotong University, 2009. (in Chinese)

[20] Zhu Wenqing. Research on performance evaluation of listed companies in the pharmaceutical industry [D]. Nanjing University of Aeronautics and Astronautics, 2016. (in Chinese)

[21] Yuan Jing. The current situation and characteristics of the domestic and international pharmaceutical industry [J]. China Economic and Trade, 2007 (11): 66-71. (in Chinese)

[22] Su Wei. Empirical research on the growth of R&D investment of pharmaceutical listed companies on the growth of enterprises [D]. Northwest A&F University, 2017. (in Chinese)

[23] Wang Yi, Xu Huanzhang. Research on the Impact of Capital Structure of Manufacturing Listed Companies on Business Performance[J]. Finance and Accounting Monthly, 2017(08): 3-10. (in Chinese)

[24] Zhu Yi. The relationship between Chinese pharmaceutical enterprise value chain, profit bank and corporate performance[J]. Economic System Reform, 2006(05): 84-88. (in Chinese)

[25] Tan Tiancheng. Heterogeneity, financing constraints and R&D investment of listed companies in pharmaceutical manufacturing [D]. Anhui University of Technology, 2016. (in Chinese)

[26] Zhu Qiutian, Pan Yuxiang. An Empirical Study on the Performance Evaluation of Listed Companies in the Pharmaceutical Industry Based on Financial Perspectives[J]. Journal of Southeast University(Philosophy and Social Sciences), 2016, 18(S1): 52-54+61. (in Chinese)

[27] Qian Xiaoyi. Analysis of the Combination of Accounts Receivable Turnover Rate and Inventory Turnover Rate[J]. Finance and Accounting Monthly, 2012(20): 80-82. (in Chinese)

[28] Hermitian. Reliability and Trend Analysis of Flow Ratio and Quick Ratio - Targeting Domestic Manufacturing Listed Companies [J]. Friends of Accounting (Late), 2010 (12): 80-82. (in Chinese)

[29] Zhang Tongbin. The Influence of Structural Factors on High Performance Enterprises with Different Performance——Based on the Data of High-tech Listed Companies[J]. Economic Management,2012,34(04):149-158. (in Chinese)

[30] Yan Youhong. Research on the Impact of R&D Investment in China on the Performance Hysteresis——Taking Pharmaceutical Manufacturing Enterprises as an Example[J]. Price Theory and Practice, 2017(04): 155-158. (in Chinese)

[31] Saibal Ghosh. Productivity and Financial Structure: Evidence from Indian High-Tech Firms [R]. MPRA Paper, 2009, No. 19467: 1-18.

[32] Masulis Ronald W. The Impact of Capital Structure Changes on Firm Value,Some Estimates[J]. Journal of Finance,1983, 38, (1) : 107-126.

[33] Financial Accounting Standards Board, “FASB Discussion Memo- random—Reporting Funds Flow, Liquidity, and Financial Flexibility” 1980, p. 7.

[34] Hsieh P H, Mishra C S, Gobeli D H. The return on R&D versus capital expenditures in pharmaceutical and chemical industries[J]. IEEE Transactions on Engineering Management, 2003, 50(2):141-150.

Privacy Policy | Copyright © 2011-2024 Ivy Publisher. All Rights Reserved.

Contact: customer@ivypub.org